It is possible to identify pregnancies with trisomy 18 as part of screening programmes for Down's syndrome that use maternal age, IX fetoprotein (AFP), unconjugated oestriol (uE 3), and either total human chorionic gonadotrophin (total hCG) or its subunit, free~-hCG. While the detection rates and false positive rates using risk as the test variable have been published for maternal age with (a) AFP, uE 3, and hCG 1 2 and with (b) AFP and free~-hCG3 this has not been done for maternal age with AFP, uE 3, and free~-hCG. Here we summarise the parameters of the distributions of the markers in affected and unaffected pregnancies, and in affected pregnancies we calculate the' standard deviation for the free~-hCG and the correlation between free i3-hCG and AFP and between free~-hCG and uE 3. We then estimate the detection rates and false positive rates.
unaffected covariance from reference 4 and then dividing by the standard deviations in (a) and (c); (e) there is no available correlation between uE 3 and free~-hCG and so it is assumed to be the same as in unaffected pregnancies.
The truncation limits (that is, the range over which the distributions are Gaussian) for AFP, uE 3, and total hCG were taken from reference 2. The limits for free i3-hCG are not yet known and are therefore assumed to be the same as for total hCG because of the high correlation between these two markers. Table 1 shows the parameters for the serum markers in the detection of trisomy 18. As in Down's syndrome pregnancies, trisomy 18 pregnancies tend to have low values for AFP and uE 3, but unlike Down's pregnancies they have low levels of total hCG and free~-hCG. Table 2 shows the detection rates, false positive rates, and odds of being affected given a positive result (OAPR) when using maternal age (England and Wales, 1984-88), AFP, uE 3, and either total hCG or free~-hCG. The birth prevalence of trisomy 18 is taken as one tenth that of Down's syndrome' with a spontaneous fetal loss rate of 70% between 16 weeks and term." A mid-trimester risk cut off of 1 in 100 with AFP, uE 3, and total hCG in combination with maternal age yields a detection rate of 59% and a false positive rate of 0·19%. The OAPR at term is 1:23. With a 1% fetal loss rate due to amniocentesis" there would be 0·23 unaffected fetal losses for every term pregnancy t Calculated as the OAPR in the second trimester divided by 0-3 (the proponion of affected fetuses surviving to term), with trisomy 18. The results are similar with free p-hCG instead oftotal hCG. The addition of uE 3 to AFP and free p-hCG or total hCG is worthwhile. For example with AFP and free p-hCG, at a risk cut off of 1 in 100, the detection rate is increased by 24 percentage points and the false positive rate reduces from 0'26% to 0·18%. Such serum testing is better than recording the presence of a choroid plexus cyst by ultrasound to detect trisomy 18, which leads to about five unaffected fetal losses per case detected? -about 20 times more than using the serum markers.
Detecting pregnancies with trisomy 18 as part of a screening programme for Down's syndrome is justified if few women are selected for an amniocentesis. This can be achieved by using a risk cut off level that yields a low false positive rate. The parameters given here allow an estimate of risk to be obtained using either free p-hCG or total hCG. The two yield virtually the same performance and there is an advantage in including uE 3 in the marker combination.
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